Morgan Stanley downgraded Smith & Nephew's stock rating from overweight to equal weight on September 3, 2026.
2 reports, 1 independent
Updated Sep 8
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley downgraded Smith & Nephew's stock rating from overweight to equal weight on September 3, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Morgan Stanley
U.S. investment bank
-
Smith & Nephew
a company producing medical equipment
Nothing else this week.
Related events
- Morgan Stanley lowered its rating for CAE Inc from equal weight to underweight on August 27, 2026.
- Morgan Stanley downgraded Baidu stock to underweight from equal-weight on August 19, 2026, following the company missing Q2 earnings expectations.
- Morgan Stanley downgraded Peloton to Underweight and lowered its price target, citing structural headwinds.
- Morgan Stanley reaffirmed an overweight rating on AbbVie, and Barclays raised its price objective on September 10, 2026.
- Morgan Stanley reissued an overweight rating for Wynn Resorts, which was reported by MarketBeat.